PFE - Pfizer Inc.

NYSE - NYSE Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
12/30/2018
12/30/2017
12/30/2016
Total Revenue
53,039,000
53,647,000
52,546,000
52,824,000
Cost of Revenue
10,686,000
11,248,000
11,240,000
12,329,000
Gross Profit
42,353,000
42,399,000
41,306,000
40,495,000
Operating Expenses
Research Development
8,284,000
8,006,000
7,657,000
7,872,000
Selling General and Administrative
14,117,000
14,455,000
14,784,000
14,837,000
Total Operating Expenses
27,232,000
27,354,000
27,199,000
26,765,000
Operating Income or Loss
15,121,000
15,045,000
14,107,000
13,730,000
Interest Expense
1,528,000
1,316,000
1,270,000
1,186,000
Total Other Income/Expenses Net
4,372,000
-2,178,000
-923,000
-4,663,000
Income Before Tax
18,244,000
11,885,000
12,305,000
8,351,000
Income Tax Expense
2,002,000
706,000
-9,049,000
1,123,000
Income from Continuing Operations
16,242,000
11,179,000
21,353,000
7,229,000
Net Income
16,216,000
11,153,000
21,308,000
7,215,000
Net Income available to common shareholders
16,215,000
11,153,000
21,308,000
7,215,000
Reported EPS
Basic
-
1.90
3.57
1.18
Diluted
-
1.87
3.52
1.17
Weighted average shares outstanding
Basic
-
5,872,000
5,970,000
6,089,000
Diluted
-
5,977,000
6,058,000
6,159,000
EBITDA
-
18,094,000
18,333,000
13,593,000